- Poster presentation
- Open Access
Respiratory self navigated whole-heart angiography with ultra-small super-paramagnetic iron oxide particles: a feasibility study
© Piccini et al. 2016
- Published: 27 January 2016
- Gadolinium Base Contrast Agent
- Vessel Segmentation
- Intravascular Contrast Agent
- Base Contrast Agent
Self-navigation (SN) in 3D radial segmented MR imaging  has been shown to be an efficient and robust method for depiction of coronary luminal anatomy using MRI. This method has largely been used at 1.5T using SSFP readouts to provide the high blood to myocardium contrast required for vessel segmentation and SN. However, bSSFP imaging is often confounded by off-resonance artifacts at higher field strengths and conventional Gadolinium based contrast agents combined with inversion-recovery preparation and gradient-echo readouts often cannot achieve a constant signal throughout the scan. Variable contrast throughout the acquisition can cause deterioration in the SN signal and therefore of the motion correction. Here we investigate the use of an intravascular contrast agent (USPIO) with long half-life as a potential method to improve the performance of the SN approach at 3T.
Eight healthy volunteers were recruited in accordance with local ethical approval. Segmented, 3D ECG triggered, SN data was acquired using a prototype 3D radial sequence  on a 3T system (MAGNETOM Verio, Siemens Healthcare). Optimal tissue contrast was empirically obtained using an inversion time of 300 ms to provide good myocardial suppression and appropriate enhancement of the blood pool over at least a 40-50 min window (allowing repeat imaging if required). Intravenous ferumoxytol (510 mg of elemental iron (Fe) in 17 ml (30 mg/ml)) at a dose of 4 mg of iron (Fe)/kg of body weight was administered over a 15 min infusion (in accordance with international guidelines). In all cases both diastolic and systolic imaging was undertaken and evaluated qualitatively for the reliability of the self-navigation signal and the final image quality.
We have demonstrated the feasibility of T1 shortening USPIO based contrast enhanced respiratory SN at 3T. The long lasting contrast enhancement provides a temporally and spatially constant signal and enables high quality imaging. Potential improvements include methods for automated rejection of data acquired during anomalous respiratory motion and further optimization of image contrast. The longer acting contrast agent allows additional data to be re-acquired in problematic cases. As USPIOs can be used as a biomarker for inflammation there is the potential to use this method as both an angiographic method and as a method for detection of concentration of USPIO in areas of inflammation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.